Related references
Note: Only part of the references are listed.LncRNA TRPM2-AS promotes ovarian cancer progression and cisplatin resistance by sponging miR-138-5p to release SDC3 mRNA
Yi Ding et al.
AGING-US (2021)
LINC00184 Promotes Ovarian Cancer Cells Proliferation and Cisplatin Resistance by Elevating CNTN1 Expression via Sponging miR-1305
Yuwen Han et al.
ONCOTARGETS AND THERAPY (2021)
LNC00115 Mediates Cisplatin Resistance by Regulating the miR-7/ERK Signalling Pathway in Ovarian Cancer
Xinyan Jiang et al.
CANCER MANAGEMENT AND RESEARCH (2021)
被撤回的出版物: NEAT1 Overexpression Indicates a Poor Prognosis and Induces Chemotherapy Resistance via the miR-491-5p/SOX3 Signaling Pathway in Ovarian Cancer (Retracted article. See vol. 13, 2022)
Xinzhuan Jia et al.
FRONTIERS IN GENETICS (2021)
circ_C20orf11 enhances DDP resistance by inhibiting miR-527/YWHAZ through the promotion of extracellular vesicle-mediated macrophage M2 polarization in ovarian cancer
Jun Yin et al.
CANCER BIOLOGY & THERAPY (2021)
LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/SDC4 axis
Yue Wu et al.
CANCER CELL INTERNATIONAL (2021)
Long non-coding RNA HAND2-AS1/miR-106a/PTEN axis re-sensitizes cisplatin-resistant ovarian cells to cisplatin treatment
Lijun Li et al.
MOLECULAR MEDICINE REPORTS (2021)
The lncRNA 'UCA1' modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels
Anais Wambecke et al.
MOLECULAR ONCOLOGY (2021)
HOTTIP-miR-205-ZEB2 Axis Confers Cisplatin Resistance to Ovarian Cancer Cells
Yu-Jie Dong et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
miR-29c-3p inhibits autophagy and cisplatin resistance in ovarian cancer by regulating FOXP1/ATG14 pathway
Zhenhua Hu et al.
CELL CYCLE (2020)
Cisplatin-mediated down-regulation of miR-145 contributes to up-regulation of PD-L1 via the c-Myc transcription factor in cisplatin-resistant ovarian carcinoma cells
Q. Sheng et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Potential cytotoxic and anti-metastatic effects of berberine on gynaecological cancers with drug-associated resistance
Hamed Mortazavi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
microRNA-137 downregulates MCL1 in ovarian cancer cells and mediates cisplatin-induced apoptosis
Wei Chen et al.
PHARMACOGENOMICS (2020)
Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving
De-Ying Wang et al.
CANCER RESEARCH AND TREATMENT (2020)
miR-34c Targets MET to Improve the Anti-Tumor Effect of Cisplatin on Ovarian Cancer
Shiying Yang et al.
ONCOTARGETS AND THERAPY (2020)
Regulation of MYB mediated cisplatin resistance of ovarian cancer cells involves miR-21-wnt signaling axis
Xue-yan Zhang et al.
SCIENTIFIC REPORTS (2020)
miR-548e Sponged by ZFAS1 Regulates Metastasis and Cisplatin Resistance of OC by Targeting CXCR4 and let-7a/BCL-XL/S Signaling Axis
Jing Zhang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
NEAT1 Knockdown Suppresses the Cisplatin Resistance in Ovarian Cancer by Regulating miR-770-5p/PARP1 Axis
Mingzhe Zhu et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Inhibition of RUNX1 promotes cisplatin-induced apoptosis in ovarian cancer cells
Li Xiao et al.
BIOCHEMICAL PHARMACOLOGY (2020)
miR-194-5p inhibits SLC40A1 expression to induce cisplatin resistance in ovarian cancer
Jianfa Wu et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1
Yun Zhang et al.
BIOLOGICAL RESEARCH (2020)
MiR-34a-5p/PD-L1 axis regulates cisplatin chemoresistance of ovarian cancer cells
Y. Zuo et al.
NEOPLASMA (2020)
MiR-186 bidirectionally regulates cisplatin sensitivity of ovarian cancer cells via suppressing targets PIK3R3 and PTEN and upregulating APAF1 expression
Ying Xiang et al.
JOURNAL OF CANCER (2020)
miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer
Jing Sun et al.
ONCOGENE (2019)
miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes
Xiaodi Li et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Modulation of Myb-induced NF-kB-STAT3 signaling and resulting cisplatin resistance in ovarian cancer by dietary factors
Miao Tian et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Role of MAML1 in targeted therapy against the esophageal cancer stem cells
Meysam Moghbeli et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer
Zewu Li et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
被撤回的出版物: Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway (Retracted article. See vol. 20, 2022)
Jun Dai et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Effects of microRNA-1271 on ovarian cancer via inhibition of epithelial-mesenchymal transition and cisplatin resistance
Yanyan Chen et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2019)
MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
Dominik Bieg et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2019)
Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A
Hua Guo et al.
CANCER CELL INTERNATIONAL (2019)
MiR-34c/SOX9 axis regulates the chemoresistance of ovarian cancer cell to cisplatin-based chemotherapy
Songshu Xiao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
NF1 regulates apoptosis in ovarian cancer cells by targeting MCL1 via miR-142-5p
Jiancheng Su et al.
PHARMACOGENOMICS (2019)
MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B
Qin Niu et al.
YONSEI MEDICAL JOURNAL (2019)
Role of MAML1 and MEIS1 in Esophageal Squamous Cell Carcinoma Depth of Invasion
Mohammad Reza Abbaszadegan et al.
PATHOLOGY & ONCOLOGY RESEARCH (2018)
Downregulation of miR-503 contributes to the development of drug resistance in ovarian cancer by targeting PI3K p85
Di Wu et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2018)
MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based chemotherapy through regulation of ATP7A/B
Fang Xiao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
MiR-514 attenuates proliferation and increases chemoresistance by targeting ATP binding cassette subfamily in ovarian cancer
Sha Xiao et al.
MOLECULAR GENETICS AND GENOMICS (2018)
MiRNA-409-3p enhances cisplatin-sensitivity of ovarian cancer cells by blocking the autophagy mediated by Fip200
Yue Cheng et al.
ONCOLOGY RESEARCH (2018)
The role of HIF-1α in chemo-/radioresistant tumors
Yu Xia et al.
ONCOTARGETS AND THERAPY (2018)
miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting Dicer1
Yanan Wang et al.
CELL DEATH & DISEASE (2018)
MiR-335-5p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2
Ruonan Liu et al.
CANCER MEDICINE (2018)
MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R
Yong Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
miR-378a-3p sensitizes ovarian cancer cells to cisplatin through targeting MAPK1/GRB2
Zhi-hong Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
STAT3 regulated miR-216a promotes ovarian cancer proliferation and cisplatin resistance
Pengfei Jin et al.
BIOSCIENCE REPORTS (2018)
WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma
Mohammad Reza Abbaszadegan et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2018)
miR-205-5p Mediated Downregulation of PTEN Contributes to Cisplatin Resistance in C13K Human Ovarian Cancer Cells
Xiaoyan Shi et al.
FRONTIERS IN GENETICS (2018)
Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun
Ying Jiang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition
Lanqin Cao et al.
BMB REPORTS (2018)
The association between copper transporters and the prognosis of cancer patients undergoing chemotherapy: a meta-analysis of literatures and datasets
Si Sun et al.
ONCOTARGET (2017)
Epidemiology and treatment patterns of epithelial ovarian cancer
Philip Jessmon et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis
Hyosun Cho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
MicroRNA-146a-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes
Xiaodi Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3β/β-catenin/cyclin D1 signaling pathway in ER-negative breast cancer
Song Gao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
miR-509-3p promotes cisplatin-induced apoptosis in ovarian cancer cells through the regulation of anti-apoptotic genes
Wei Chen et al.
PHARMACOGENOMICS (2017)
miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α
Xue Feng et al.
ONCOTARGETS AND THERAPY (2017)
Nrf2 induces cisplatin resistance via suppressing the iron export related gene SLC40A1 in ovarian cancer cells
Jianfa Wu et al.
ONCOTARGET (2017)
Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasis
Fatemeh Vafaee et al.
SCIENTIFIC REPORTS (2017)
A Feedback Loop Between miR-30a/c-5p and DNMT1 Mediates Cisplatin Resistance in Ovarian Cancer Cells
Xi Han et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38
Katharina Gohr et al.
BMC CANCER (2017)
Restoration of microRNA-708 sensitizes ovarian cancer cells to cisplatin via IGF2BP1/Akt pathway
Xuying Qin et al.
CELL BIOLOGY INTERNATIONAL (2017)
Regulatory players of DNA damage repair mechanisms: Role in Cancer Chemoresistance
Kunnathur Murugesan Sakthivel et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1
Y. Liu et al.
CANCER GENE THERAPY (2017)
Epigenetic therapy for the treatment of epithelial ovarian cancer: A clinical review
Haller J. Smith et al.
GYNECOLOGIC ONCOLOGY REPORTS (2017)
Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer
Mei Xue et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin
X. Zhu et al.
ONCOGENE (2016)
Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells
Priya Samuel et al.
TUMOR BIOLOGY (2016)
Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β-catenin pathway in human ovarian cancer
Jing Li et al.
TUMOR BIOLOGY (2016)
The autophagy-related protein LC3 is processed in stallion spermatozoa during short-and long-term storage and the related stressful conditions
I. M. Aparicio et al.
ANIMAL (2016)
SOX9 Elevation Acts with Canonical WNT Signaling to Drive Gastric Cancer Progression
Juliana Carvalho Santos et al.
CANCER RESEARCH (2016)
Gal-3 does not suppress cisplatin-induced apoptosis in A-375 melanoma cells
Malgorzata Pokrywka et al.
CELL BIOLOGY INTERNATIONAL (2016)
Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application
Masaki Mandai et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2016)
miR-100 resensitizes resistant epithelial ovarian cancer to cisplatin
Peng Guo et al.
ONCOLOGY REPORTS (2016)
MicroRNA-509-3p increases the sensitivity of epithelial ovarian cancer cells to cisplatin-induced apoptosis
Wei Chen et al.
PHARMACOGENOMICS (2016)
PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cells
Noemi Arrighetti et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
MicroRNA-155 promotes apoptosis in SKOV3, A2780, and primary cultured ovarian cancer cells
Wei Chen et al.
TUMOR BIOLOGY (2016)
MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1
Di-di Wu et al.
TUMOR BIOLOGY (2016)
BIRC3 alterations in chronic and B-cell acute lymphocytic leukemia patients
Eyad Alhourani et al.
ONCOLOGY LETTERS (2016)
MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2
Henan Zhao et al.
ONCOTARGET (2016)
MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1
Songyu Tian et al.
ONCOTARGET (2016)
Targeted agents in epithelial ovarian cancer: review on emerging therapies and future developments
Rajitha Lokadasan et al.
ECANCERMEDICALSCIENCE (2016)
Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function
Carla Garza-Lombo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
SOX9 Overexpression Promotes Glioma Metastasis via Wnt/β-Catenin Signaling
Hongwei Liu et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
The role of ABC transporters in ovarian cancer progression and chemoresistance
M. P. Ween et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway
Marijn T. M. van Jaarsveld et al.
MOLECULAR CANCER (2015)
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
Shabnam Shalapour et al.
NATURE (2015)
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer et al.
NATURE (2015)
Disruption of PARP1 function inhibits base excision repair of a sub-set of DNA lesions
Pamela Reynolds et al.
NUCLEIC ACIDS RESEARCH (2015)
Integrated analysis of DNA methylation and microRNA regulation of the lung adenocarcinoma transcriptome
Jiang Du et al.
ONCOLOGY REPORTS (2015)
MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1
Kai-Xuan Sun et al.
JOURNAL OF OVARIAN RESEARCH (2015)
MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1
Shaohua Xu et al.
ONCOTARGET (2015)
The clinical and functional significance of c-Met in breast cancer: a review
Colan M. Ho-Yen et al.
BREAST CANCER RESEARCH (2015)
PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
HaiXia Li et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2014)
Kinase mTOR: Regulation and role in maintenance of cellular homeostasis, tumor development, and aging
A. A. Parkhitko et al.
BIOCHEMISTRY-MOSCOW (2014)
MicroRNAs and their relevance to ABC transporters
Sierk Haenisch et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Prevalence and Clinicopathologic Correlates of O6-Methylguanine-DNA Methyltransferase Methylation Status in Patients With Triple-Negative Breast Cancer Treated Preoperatively by Alkylating Drugs
Caterina Fumagalli et al.
CLINICAL BREAST CANCER (2014)
Poly(ADP-ribose) polymerases in double-strand break repair: Focus on PARP1, PARP2 and PARP3
Carole Beck et al.
EXPERIMENTAL CELL RESEARCH (2014)
Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cells
Pei-Ning Yu et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
CXC chemokine ligand 12 (CXCL12) and its receptor CXCR4
Takashi Nagasawa
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Oncogenic roles of EMT-inducing transcription factors
Alain Puisieux et al.
NATURE CELL BIOLOGY (2014)
MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine
Y. Xiang et al.
ONCOGENE (2014)
Expression of miR-224-5p is associated with the original cisplatin resistance of ovarian papillary serous carcinoma
Henan Zhao et al.
ONCOLOGY REPORTS (2014)
Upregulation of miR-21 in Cisplatin Resistant Ovarian Cancer via JNK-1/c-Jun Pathway
Ileabett M. Echevarria-Vargas et al.
PLOS ONE (2014)
The Met receptor tyrosine kinase: A key player in oncogenesis and drug resistance
Christiane R. Maroun et al.
PHARMACOLOGY & THERAPEUTICS (2014)
MicroRNA-449a reduces cell survival and enhances cisplatin-induced cytotoxicity via downregulation of NOTCH1 in ovarian cancer cells
Yanqi Zhou et al.
TUMOR BIOLOGY (2014)
miR-101 regulates expression of EZH2 and contributes to progression of and cisplatin resistance in epithelial ovarian cancer
Lin Liu et al.
TUMOR BIOLOGY (2014)
MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP
Yingxin Pang et al.
ONCOTARGETS AND THERAPY (2014)
microRNA-106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells
Hao Li et al.
ONCOLOGY LETTERS (2014)
Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis
Beben Benyamin et al.
NATURE COMMUNICATIONS (2014)
PARP1-Driven Poly-ADP-Ribosylation Regulates BRCA1 Function in Homologous Recombination-Mediated DNA Repair
Yiduo Hu et al.
CANCER DISCOVERY (2014)
Expression and Clinical Significance of the Autophagy Proteins BECLIN 1 and LC3 in Ovarian Cancer
Guido Valente et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly
Xi'an Zhang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review
Asfar S. Azmi et al.
CANCER AND METASTASIS REVIEWS (2013)
Cancer genetics and genomics of human FOX family genes
Masuko Katoh et al.
CANCER LETTERS (2013)
Cisplatin Selects for Multidrug-Resistant CD133(+) Cells in Lung Adenocarcinoma by Activating Notch Signaling
Yu-Peng Liu et al.
CANCER RESEARCH (2013)
Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
Jessica L. Bell et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
Zachary C. Dobbin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
MiR-106a Targets Mcl-1 to Suppress Cisplatin Resistance of Ovarian Cancer A2780 Cells
Yu-mei Rao et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2013)
miR-9 Regulation of BRCA1 and Ovarian Cancer Sensitivity to Cisplatin and PARP Inhibition
Chaoyang Sun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
M. T. M. van Jaarsveld et al.
ONCOGENE (2013)
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
X. Sui et al.
CELL DEATH & DISEASE (2013)
microRNA-199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin
Zhongxian Wang et al.
ONCOLOGY LETTERS (2013)
Regulation of Apoptosis by Inhibitors of Apoptosis (IAPs)
Jean Berthelet et al.
Cells (2013)
Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms
Qian Qin et al.
CELL RESEARCH (2012)
The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs
L. A. Stivala et al.
CURRENT CANCER DRUG TARGETS (2012)
Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells
Xin Fu et al.
FEBS LETTERS (2012)
Colon cancer associated transcript-1: A novel RNA expressed in malignant and pre-malignant human tissues
Aviram Nissan et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Ovarian cancer risk factors by histologic subtypes in the NIH-AARP diet and health study
Hannah P. Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
DNA methylation and microRNA dysregulation in cancer
Hiromu Suzuki et al.
MOLECULAR ONCOLOGY (2012)
Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy
Seok-Hyun Kim et al.
LUNG CANCER (2012)
Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance
W. Li et al.
ONCOGENE (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance
Lingyun Yang et al.
ONCOLOGY REPORTS (2012)
Role of KCNMA1 in Breast Cancer
Martin Oeggerli et al.
PLOS ONE (2012)
Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy
Shannon M. McAuliffe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo
Jianfeng Guo et al.
CANCER SCIENCE (2011)
Transient silencing of galectin-3 expression promotes both in vitro and in vivo drug-induced apoptosis of human pancreatic carcinoma cells
Tsutomu Kobayashi et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer
Mi Jeong Kwon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1
Fanfei Kong et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2011)
The p53 Upregulated Modulator of Apoptosis (PUMA) Chemosensitizes Intrinsically Resistant Ovarian Cancer Cells to Cisplatin by Lowering the Threshold Set by Bcl-xL and Mcl-1
Zhu Yuan et al.
MOLECULAR MEDICINE (2011)
Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer
D. Reimer et al.
ONCOGENE (2011)
Specific Thiazolidinediones Inhibit Ovarian Cancer Cell Line Proliferation and Cause Cell Cycle Arrest in a PPARγ Independent Manner
Linah Al-Alem et al.
PLOS ONE (2011)
Conserved BK Channel-Protein Interactions Reveal Signals Relevant to Cell Death and Survival
Bernd Sokolowski et al.
PLOS ONE (2011)
c-MYC Suppresses BIN1 to Release Poly(ADP-Ribose) Polymerase 1: A Mechanism by Which Cancer Cells Acquire Cisplatin Resistance
Slovenie Pyndiah et al.
SCIENCE SIGNALING (2011)
MicroRNAs and Cancer: Introduction
Ramiro Garzon et al.
SEMINARS IN ONCOLOGY (2011)
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan et al.
NATURE REVIEWS CANCER (2011)
E2F3a Is Critically Involved in Epidermal Growth Factor Receptor-Directed Proliferation in Ovarian Cancer
Daniel Reimer et al.
CANCER RESEARCH (2010)
NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease Outcome
Michael Holzel et al.
CELL (2010)
Targeting Polo-like Kinase in Cancer Therapy
Yan Degenhardt et al.
CLINICAL CANCER RESEARCH (2010)
Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1
Yoshimi Arima et al.
EXPERIMENTAL DERMATOLOGY (2010)
ERK and cell death: Mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence
Sebastien Cagnol et al.
FEBS JOURNAL (2010)
p27Kip1 Mediates Addiction of Ovarian Cancer Cells to MYCC (c-MYC) and Their Dependence on MYC Paralogs
Tulsiram Prathapam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Rajnish A. Gupta et al.
NATURE (2010)
Integrin signalling adaptors: not only figurants in the cancer story
Sara Cabodi et al.
NATURE REVIEWS CANCER (2010)
Bcl2 family proteins in carcinogenesis and the treatment of cancer
Anna Frenzel et al.
APOPTOSIS (2009)
Increased Frequency and Suppression by Regulatory T Cells in Patients with Acute Myelogenous Leukemia
Miroslaw J. Szczepanski et al.
CLINICAL CANCER RESEARCH (2009)
MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy
Todd Boren et al.
GYNECOLOGIC ONCOLOGY (2009)
Platinum compounds 30 years after the introduction of cisplatin: Implications for the treatment of ovarian cancer
Franco Muggia
GYNECOLOGIC ONCOLOGY (2009)
Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells
Karin Simonin et al.
MOLECULAR CANCER THERAPEUTICS (2009)
RNF2 is the target for phosphorylation by the p38 MAPK and ERK signaling pathways
Prema S. Rao et al.
PROTEOMICS (2009)
Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells
Ganna V. Kalayda et al.
BMC CANCER (2008)
Structural basis for sorting mechanism of p62 in selective autophagy
Yoshinobu Ichimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer
William M. Merritt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Critical role of c-Jun overexpression in liver metastasis of human breast cancer xenograft model
Yan Zhang et al.
BMC CANCER (2007)
PD-1 and its ligands in T-cell immunity
Mary E. Keir et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response
Bin Wang et al.
SCIENCE (2007)
MAP kinase signalling pathways in cancer
A. S. Dhillon et al.
ONCOGENE (2007)
The Bcl-2 apoptotic switch in cancer development and therapy
J. M. Adams et al.
ONCOGENE (2007)
Involvement of programmed cell death 4 in transforming growth factor-β1-induced apoptosis in human hepatocellular carcinoma
H. Zhang et al.
ONCOGENE (2006)
MicroRNAs - Critical regulators of development, cellular physiology and malignancy
JT Mendell
CELL CYCLE (2005)
Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1α
RJ Phillips et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors
B Dasgupta et al.
CANCER RESEARCH (2005)
Role of chemotherapy in the management of epithelial ovarian cancer
NS Reed et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2005)
Mitogen-activated protein kinases in cell-cycle control
RA MacCorkle et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2005)
The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3
R Cao et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2004)
CXCR4 regulates growth of both primary and metastatic breast cancer
MCP Smith et al.
CANCER RESEARCH (2004)
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
PK Majumder et al.
NATURE MEDICINE (2004)
Myc pathways provoking cell suicide and cancer
JA Nilsson et al.
ONCOGENE (2003)
The Bcl-2 family: roles in cell survival and oncogenesis
S Cory et al.
ONCOGENE (2003)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal
T Tsuruo et al.
CANCER SCIENCE (2003)
Core-binding factors in haematopoiesis and leukaemia
NA Speck et al.
NATURE REVIEWS CANCER (2002)
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
GL Niu et al.
ONCOGENE (2002)
Involvement of protein kinase C-δ in DNA damage-induced apoptosis
A Basu et al.
CELL DEATH AND DIFFERENTIATION (2001)
Recognition of cisplatin adducts by cellular proteins
M Kartalou et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin
A Bhattacharyya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
